PFE - Pfizer Inc.
25.6
-0.110 -0.430%
Share volume: 36,532,213
Last Updated: 03-13-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.01%
PREVIOUS CLOSE
CHG
CHG%
$25.71
-0.11
0.00%
Summary score
43%
Profitability
39%
Dept financing
26%
Liquidity
63%
Performance
45%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2020 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
5.43%
Return on assets
2.47%
Return on sales
21.37%
Return on invested capital
5.2%
Total debt ratio
56.17%
Debt ratio change over timeo
6.52%
Current Ratio
1.38%
Quick Ratio
1.13%
Cash Position Ratio
0.57%
Short-term ratios 31-Dec-2023 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
3.38%
Return on assets
0.99%
Return on sales
19.26%
Return on invested capital
2.25%
Total debt ratio
58.58%
Debt ratio change over timeo
0.15%
Current Ratio
1.02%
Quick Ratio
0.76%
Cash Position Ratio
0.09%
Last quarter ratios 31-Dec-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-0.01%
Return on sales
13.21%
Return on invested capital
0%
Total debt ratio
58.67%
Debt ratio change over time
0%
Current Ratio
1.17%
Quick Ratio
0.92%
Cash Position Ratio
0.02%
Performance ratios (change over 4 years) 31-Dec-2020 - 31-Dec-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-31.34%
Return on assets
-56.84%
Return on sales
287.69%
Return on invested capital
-30.85%
Total debt ratio
651.6%
Debt ratio change over time
6.52%
Current Ratio
15.06%
Quick Ratio
11.98%
Cash Position Ratio
4.94%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | PFE | LLY | NVO | NONOF |
---|---|---|---|---|
Return on equity | 5.43% | 15.71% | 0% | 0% |
Return on assets | 2.47% | 4.24% | 0% | 0% |
Return on sales | 21.37% | 28.08% | 0% | 0% |
Return on invested capital | 5.2% | 9.78% | 0% | 0% |
Profitability | 56% | 100% | 0% | 0% |
Total debt ratio | 56.17% | 81.31% | 0% | 0% |
Debt ratio change over time | 6.52% | -15.58% | 0% | 0% |
Dept financing | 42% | 25% | 0% | 0% |
Current Ratio | 1.02% | 1.25% | 0% | 0% |
Quick Ratio | 0.76% | 0.96% | 0% | 0% |
Cash Position Ratio | 0.09% | 0.13% | 0% | 0% |
Liquididy | 75% | 49% | 0% | 0% |
Short-term ratios | PFE | LLY | NVO | NONOF |
---|---|---|---|---|
Return on equity | 3.38% | 17.51% | 0% | 0% |
Return on assets | 0.99% | 4.29% | 0% | 0% |
Return on sales | 19.26% | 28.55% | 0% | 0% |
Return on invested capital | 2.25% | 11.13% | 0% | 0% |
Profitability | 33% | 100% | 0% | 0% |
Total debt ratio | 58.58% | 80.84% | 0% | 0% |
Debt ratio change over time | 0.15% | 4.11% | 0% | 0% |
Dept financing | 19% | 50% | 0% | 0% |
Current Ratio | 1.02% | 1.25% | 0% | 0% |
Quick Ratio | 0.76% | 0.96% | 0% | 0% |
Cash Position Ratio | 0.09% | 0.13% | 0% | 0% |
Liquididy | 57% | 75% | 0% | 0% |